XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.2
Related Parties Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 16, 2022
Feb. 24, 2015
Sep. 30, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2019
Dec. 31, 2018
Dec. 01, 2021
Sep. 30, 2021
Sep. 07, 2021
Jul. 01, 2020
Related Parties Transactions (Details) [Line Items]                            
Current amount $ 1,000,000                          
Bears interest 5.00%                          
Working capital percentage 6.40%                          
Conversion price, description The Company may convert the Note at any time into shares of Rgene’s common stock at either (i) a fixed conversion price equal to $1.00 per share or (ii) 20% discount of the stock price of the then most recent offering, whichever is lower; the conversion price is subject to adjustment as set forth in the Note. The Note includes standard events of default, as well as a cross default provision pursuant to which a breach of the Service Agreement will trigger an event of default under the convertible note if not cured after 5 business days of written notice regarding the breach is provided.                          
Balance of outstanding loans           $ 500,000   $ 500,000            
Accrued interest           $ 26,126   13,819            
Loan agreement total amount               507,000            
Interest rate       6.50%   6.50%                
Research fee       $ 308,650.58   $ 308,650.58                
Loan agreement, description                   The advances bear interest rate of 12% per annum.        
Due amount       111,434   111,434   112,822            
Outstanding advance       495,753   495,753   188,753            
Outstanding principal and accrued interest       149,586   149,586   151,450            
Interest expenses       $ 5,171 $ 5,401 10,067 $ 10,714              
AUSTRALIA                            
Related Parties Transactions (Details) [Line Items]                            
Loan agreements           88,091                
BioFirst (Australia) [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Balance of outstanding loans           313,606   275,901            
Accrued interest           $ 1,174,370                
Due from rgene amounted                     $ 250,000     $ 361,487
Interest rate percentage                       6.50%    
Loan settled amount                         $ 67,873  
Ownership percentage       6.50%   6.50%                
Research fee               1,028,556            
Jiangs [Member] | Minimum [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Ownership percentage       0.00%   0.00%                
Jiangs [Member] | Maximum [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Ownership percentage       1.00%   1.00%                
Forecast [Member] | AUSTRALIA                            
Related Parties Transactions (Details) [Line Items]                            
Loan agreements     $ 25,500                      
BHK Co Development Agreement [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Loan agreement, description   The development costs shall be shared 50/50 between BHK and the Company. Under the term of the agreement, BioLite issued relevant development cost to BHK.                        
BioFirst [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Loan agreement, description                 The advances bear interest 1% per month (or equivalent to 12% per annum).          
Jiangs [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Outstanding advance       $ 19,789   $ 19,789   $ 19,789            
BioFirst [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Maturity date       Nov. 30, 2022   Nov. 30, 2022